The Effects of Preoperative Glycaemic Control (HbA1c) on Bariatric and Metabolic Surgery Outcomes: Data from a Tertiary-Referral Bariatric Centre in the UK
Rattachement africain : gb, sa. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Current recommendations advocate the achievement of an optimal glucose control (HbA1c < 69 mmol/mol) prior to elective surgery to reduce risks of peri- and post-operative complications, but the relevance for this glycaemic threshold prior to Bariatric Metabolic Surgery (BMS) following a specialist weight management programme remains unclear. METHODS: We undertook a retrospective cohort study of patients with type 2 diabetes mellitus (T2DM) who underwent BMS over a 6-year period (2016-2022) at a regional tertiary referral following completion of a specialist multidisciplinary weight management. Post-operative outcomes of interest included 30-day mortality, readmission rates, need for Intensive Care Unit (ICU) care and hospital length of stay (LOS) and were assessed according to HbA1c cut-off values of < 69 (N = 202) and > 69 mmol/mol (N = 67) as well as a continuous variable. RESULTS: A total of 269 patients with T2D were included in this study. Patients underwent primary Roux en-Y gastric bypass (RYGB, n = 136), Sleeve Gastrectomy (SG, n = 124), insertion of gastric band (n = 4) or one-anastomosis gastric bypass (OAGB, n = 4). No significant differences in the rates of complications were observed between the two groups of pre-operative HbA1c cut-off values. No HbA1c threshold was observed for glycaemic control that would affect the peri- and post-operative complications following BMS. CONCLUSIONS: We observed no associations between pre-operative HbA1C values and the risk of peri- and post-operative complications. In the context of a specialist multidisciplinary weight management programme, optimising pre-operative HbA1C to a recommended target value prior to BMS may not translate into reduced risks of peri- and post-operative complications.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The Effects of Preoperative Glycaemic Control (HbA1c) on Bariatric and Metabolic Surgery Outcomes: Data from a Tertiary-Referral Bariatric Centre in the UK
- Date Crossref
- 15/01/2024
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Nottingham Clinical pays non établi dans la noticeUniversité ou école supérieure
-
Royal Derby Hospital pays non établi dans la noticeÉtablissement de santé
-
Arthritis UK pays non établi dans la noticeOrganisation à but non lucratif
-
Nottingham Biomedical Research Centre pays non établi dans la noticeStructure de recherche
-
University Hospitals of Derby and Burton NHS Foundation Trust pays non établi dans la noticeÉtablissement de santé
-
Saudi Electronic University pays non établi dans la noticeUniversité ou école supérieure
-
National Institute for Health and Care Research pays non établi dans la noticeOrganisme public
-
University Hospitals of Derby & Burton NHS Foundation Trust East Midlands Bariatric & Metabolic Institute (EMBMI) pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Public Health pays non établi dans la noticeUniversité ou école supérieure
Clinical — University of Nottingham, Royal Derby Hospital et Arthritis UK, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.